SBIR/STTR Research Award

NeuroPredict, A screening assay for chemicals that affect the differentiation of human neural cells.

Award identifier 9d01e63ef38b227de4eb759470374128176d264dc1f8a256f6eef2969839ae19Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,497,446

Program and phase

SBIR · Phase II

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
NZUMBE INC
Proposal award date
2018-08-01
Contract end date
2020-07-31
UEI
NSVYJ517CHC5
Solicitation number
ES17-007
Topic code
NIEHS

Research abstract

ABSTRACT A growing human health concern is that exposure to chemicals in our environment harms the highly vulnerable period of human brain developmentIndeedincreasing evidence shows that even simpleacute exposures of the developing brain to select agents cause profound neurological disorders such as epilepsyautism and intellectual disabilityDespite this vulnerabilitythe reliablehigh throughput identification of neurotoxins that affect this process has been laggingMajor hurdles include the time and cost required for these assays when using animal modelsthe difficulty of relating rodent data to human brain developmentand the difficulty in generating easy to interpret metrics for how a chemical affects the multiple cell types required for proper neurodevelopmentNzumbe Increceived a Phase I grant to address these challengesOur work established and validated awellhigh content assay that determines whether a chemical affects neural differentiationWe identified discrete timepoints and cell specific markers that can be used to screen for aberrant changes in neural differentiation following exposures to chemicalsWe are now seeking Phase II SBIR funding in response to RFA ESNovel Assays for Screening the Effects of Chemical Toxicants on Cell DifferentiationOur plans under Phase II are to further innovate and deliver a more rapidpredictive testcalled NeuroPredictTMwhich would greatly reduce cost and give simpleeasy to interpret metrics to determine how a chemical affects neural differentiationOur first Aim is to create specially engineered human iPSC derived neural progenitor cellshNPCsthat express reporter proteins that identify the basic cell types that arise during neural differentiationThese reporter proteins can be assayed at multiple time points during the differentiation processThe ratio of these different reporter proteins will represent the relative proportion of the basic cells type present during neural differentiationhNPCglial cellsand neuronsThusa toxic effect of chemical exposure on the differentiation process will be reflected by changes in the reporter protein outputsThe second Aim is to use the NeuroPredictTM assay to classify the early functional and disease associated effects of known neurotoxins on neural differentiationThis strategy will provide data for a short term assay that can quickly classify chemicals with unknown neurotoxic effects PROJECT NARRATIVE The period of active neural differentiation is particularly sensitive to chemical exposuresHoweverin vitro screening assays to detect chemical perturbations of the neural differentiation process are lackingThe objective of this application is to build on our Phase I proof of concept work and commercialize NeuroPredictTMa low costeasily scalable screening assay to identify chemicals that perturb neural differentiation

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

6 SBIR/STTR records share this UEI (2014–2023). Reported award amounts total $3,753,928. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.